TrialNeuro-oncology2026

Discrepancies in inter-rater agreement on resectability of recurrent glioblastoma: Complementary post-hoc analysis of the prospective, randomized DIRECTOR trial.

Philipp Karschnia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.